Response to «Security and effectivity from the dapagliflozin with other inhibitor of the SGLT-2: What decision to take?

Saved in:
Bibliographic Details
Published inSemergen, medicina de familia Vol. 48; no. 3; p. 220
Main Authors Pallarés Carratalá, V, Escobar Cervantes, C
Format Journal Article
LanguageEnglish
Spanish
Published Spain 01.04.2022
Subjects
Benzhydryl Compounds - therapeutic use
Diabetes Mellitus, Type 2 - drug therapy
Glucosides - pharmacology
Glucosides - therapeutic use
Humans
Hypoglycemic Agents - pharmacology
Online AccessGet full text

Cover

More Information
ISSN:1578-8865
DOI:10.1016/j.semerg.2022.01.012